Adrenergic regulation of bone metabolism: Possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells
- 15 July 2002
- journal article
- review article
- Published by Wiley in Microscopy Research and Technique
- Vol. 58 (2) , 77-84
- https://doi.org/10.1002/jemt.10121
Abstract
It has been demonstrated that human osteoblastic as well as osteoclastic cells are equipped with adrenergic receptors and neuropeptide receptors and that they constitutively express diffusible axon guidance molecules that are known to function as a chemoattractant and/or chemorepellent for growing nerve fibers. These findings suggest that the extension of axons of sympathetic and peripheral sensory neurons to osteoblastic and osteoclastic cells is required for the dynamic neural regulation of local bone metabolism. Recently, bone resorption modulated by sympathetic stimulation was demonstrated to be associated with ODF (osteoclast differentiation factor) and OCIF (osteoclastogenesis inhibitory factor) produced by osteoblasts/stromal cells. This review summarizes the evidence implicating sympathetic neuron action in bone metabolism. The possible function of osteoclastogenesis, which could result in the initiation of sympathomimetic bone resorption, is also discussed. Microsc. Res. Tech. 58:77–84, 2002.Keywords
This publication has 71 references indexed in Scilit:
- The Inhibitory Effects of Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide on Osteoclast Formation Are Associated with Upregulation of Osteoprotegerin and Downregulation of RANKL and RANKBiochemical and Biophysical Research Communications, 2000
- Substance P Regulates the Function of Rabbit Cultured Osteoclast; Increase of Intracellular Free Calcium Concentration and Enhancement of Bone ResorptionBiochemical and Biophysical Research Communications, 1999
- Potential Role of Cbfa1, an Essential Transcriptional Factor for Osteoblast Differentiation, in Osteoclastogenesis: Regulation of mRNA Expression ofOsteoclast Differentiation Factor(ODF)Biochemical and Biophysical Research Communications, 1998
- Transforming Growth Factor-β1 Increases mRNA Levels of Osteoclastogenesis Inhibitory Factor in Osteoblastic/Stromal Cells and Inhibits the Survival of Murine Osteoclast-like CellsBiochemical and Biophysical Research Communications, 1998
- Osteoprotegerin Production by Human Osteoblast Lineage Cells Is Stimulated by Vitamin D, Bone Morphogenetic Protein-2, and CytokinesBiochemical and Biophysical Research Communications, 1998
- Osteoprotegerin mRNA Is Increased by Interleukin-1α in the Human Osteosarcoma Cell Line MG-63 and in Human Osteoblast-Like CellsBiochemical and Biophysical Research Communications, 1998
- Regulation of alkaline phosphatase and alpha2(I) procollagen synthesis during early intramembranous bone formation in the rat mandibleDifferentiation, 1990
- Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissuesJournal of the Autonomic Nervous System, 1988
- Parathyroid hormone and noradrenaline‐induced enhancement of cyclic AMP in a cloned osteogenic sarcoma cell line (UMR 106) is inhibited by neuropeptide YActa Physiologica Scandinavica, 1988
- In vitro calcification in human osteoblastic cell line derived from periosteumBiochemical and Biophysical Research Communications, 1987